We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDRX
376
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.84M 0.05%
195,000
+60,000
+44% +$833K
SHW icon
377
Sherwin-Williams
SHW
$78.3B
$2.83M 0.05%
20,724
+1,131
+6% +$149K
TPR icon
378
Tapestry
TPR
$28.8B
$2.78M 0.05%
62,868
-44,092
-41% -$1.82M
S
379
DELISTED
Sprint Corporation
S
$2.76M 0.05%
469,105
+8,647
+2% +$54.9K
HALO icon
380
Halozyme
HALO
$9.72B
$2.75M 0.05%
136,000
-23,000
-14% -$423K
TRP icon
381
TC Energy
TRP
$73.5B
$2.72M 0.05%
55,760
+14,084
+34% +$688K
BN icon
382
Brookfield
BN
$102B
$2.7M 0.05%
173,060
+3,938
+2% +$59.5K
CNQ icon
383
Canadian Natural Resources
CNQ
$96.9B
$2.68M 0.05%
152,858
+30,199
+25% +$507K
SLF icon
384
Sun Life Financial
SLF
$45.6B
$2.68M 0.05%
64,788
+757
+1% +$30.2K
ATVI
385
DELISTED
Activision Blizzard
ATVI
$2.68M 0.05%
42,359
+1,854
+5% +$117K
PSA icon
386
Public Storage
PSA
$60.2B
$2.68M 0.05%
12,816
+856
+7% +$181K
EQIX icon
387
Equinix
EQIX
$107B
$2.65M 0.05%
5,852
+287
+5% +$133K
LXRX icon
388
Lexicon Pharmaceuticals
LXRX
$1.02B
$2.65M 0.05%
268,000
-25,000
-9% -$260K
NFX
389
DELISTED
Newfield Exploration
NFX
$2.63M 0.05%
+83,312
New +$2.53M
RETA
390
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.6M 0.05%
92,000
+32,000
+53% +$893K
HIG icon
391
Hartford Financial Services
HIG
$38.5B
$2.6M 0.05%
46,226
-340,489
-88% -$19M
COR icon
392
Cencora
COR
$60.3B
$2.59M 0.04%
28,191
-279
-1% -$23.1K
BSX icon
393
Boston Scientific
BSX
$65.8B
$2.58M 0.04%
103,853
-3,613
-3% -$99.7K
YUM icon
394
Yum! Brands
YUM
$41B
$2.55M 0.04%
31,301
-110
-0.4% -$8.7K
RSG icon
395
Republic Services
RSG
$66.7B
$2.55M 0.04%
37,689
+852
+2% +$54.9K
ROST icon
396
Ross Stores
ROST
$76.6B
$2.55M 0.04%
31,736
-220,285
-87% -$15.4M
APLS
397
DELISTED
Apellis Pharmaceuticals
APLS
$2.54M 0.04%
+117,000
New +$1.72M
KDP icon
398
Keurig Dr Pepper
KDP
$40.4B
$2.53M 0.04%
26,038
+2,363
+10% +$212K
APH icon
399
Amphenol
APH
$188B
$2.52M 0.04%
114,964
+12,292
+12% +$270K
FIS icon
400
Fidelity National Information Services
FIS
$21.5B
$2.49M 0.04%
26,482
+1,893
+8% +$178K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.